EARNINGS SUPPLEMENTAL Q4 2024 FEBRUARY 2025 OVERVIEW | Key Statistics (1) (2) | | | --- | --- | | Properties | 95 | | Hotel Rooms | 21,156 | | Share Price | $10.21 | | Total Shares and Units Outstanding | 154.1 M | | Market Capitalization | $1.6 B | | Preferred Equity | $0.3 B | | Net Debt Outstanding | $1.8 B | | Total Enterprise Value (TEV) | $3.7 B | | Total Capitalization | $4.1 B | HOTEL TONNELLE NEW ORLEANS Debt Maturity Schedule (3) (1) For properties owned as of December 31, 2024; excludes Chateau L ...

Confidential & Proprietary – Do not distribute. © 2024 Zevia PBC 1 Q4 2024 FINANCIAL RESULTS Non-GAAP Financial Information Confidential & Proprietary – Do not distribute. © 2024 Zevia PBC 2 We use Adjusted EBITDA, a financial measure in this presentation and the related earnings press release that is not calculated in accordance with U.S. generally accepted accounting principles information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a ...

Investor Presentation FULL YEAR 2024 Such forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors mentioned in "Item 1A. Risk Factors" of our most recent Annual Report on Form 10-K, as updated in subsequent filings with the SEC, will be important in determining future results. Should one or more of these risks or assumptions materialize, or should the underlying assumptions prove incorrect, actual results may vary materi ...

National Health Investors Q4 2024 Supplemental TABLE OF CONTENTS COMPANY | COMPANY INFORMATION & LEADERSHIP | 02 | | --- | --- | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | REAL ESTATE INVESTMENTS | 04 | | SENIOR HOUSING OPERATING PORTFOLIO | 05 | | OPERATING PARTNERS | 06 | | EBITDARM LEASE COVERAGE & OCCUPANCY | 07 | | PURCHASE OPTIONS & LEASE MATURITIES | 08 | | INVESTMENTS | | | INVESTMENT RATIONALE | 09 | | RECENT INVESTMENTS | 10 | | CAPITALIZATION | | | CAPITALIZATION OVERVIEW | 11 | | CAPITAL STRU ...

4Q24 & FY24 Earnings Call This presentation was prepared by Ambev S.A. ("Ambev" or "Company") for the exclusive use in the earnings conference call of the fourth quarter and full year of 2024 (4Q24 and FY24). This presentation should not be considered as a complete document and should be analyzed together with the Company's financial statements (DFP) for the year and the respective press release, both available on the U.S. Securities and Exchange Commission – SEC and the CVM website. This presentation was p ...

These materials contain forward-looking information. Words such as "anticipate," "assume," "estimate," "expect," "target" "project," "model", "predict," "intend," "plan," "believe," "potential," "may," "should" and similar expressions may identify forward-looking information. Forward-looking information in these materials includes, but is not limited to, information regarding: First Quarter 2025 outlook, including revenue, adjusted EBITDA, adjusted EBITDA margin, and earnings per share and the drivers there ...

Rhythm Pharmaceuticals Fourth Quarter, Full Year 2024 Financial Results and Business Update February 26, 2025 ® © Rhythm® Pharmaceuticals, Inc. All rights reserved. On Today's Call ® ® 3 David Meeker, MD Chair, President and CEO ® 2 • David Connolly, Executive Director of Investor Relations and Corporate Communications • David Meeker, MD, Chair, President and Chief Executive Officer • Jennifer Lee, Executive Vice President, Head of North America • Yann Mazabraud, Executive Vice President, Head of Internatio ...

FY 2024 PRESENTATION Volume/mix Recurring operating margin Recurring EPS €3.63 13.0% €3.54 +3.0% 12.6% 12.2% €3.43 -0.8% -0.4% FY 24 FY 24 FY 24 FY 22 FY 23 FY 22 FY 23 FY 22 FY 23 Free Cash Flow ROIC 10.0% €3.0 bn 9.5% €2.6 bn 8.9% €2.1 bn in 2024 FY 22 FY 24 FY 22 FY 24 FY 23 FY 23 ATNI = Global Access To Nutrition index 3 Progressively rebalancing our growth model Antoine de Saint-Affrique Chief Executive Officer CLOSING THE FIRST 3 YEARS OF RENEW DANONE CONSISTENTLY DELIVERING ON OUR GUIDANCE LEVERAGING ...

Corporate Presentation January 2025 NASDAQ: THTX TSX: TH Forward-Looking Information The following presentation contains statements that are considered forward-looking information within the meaning of securities regulation. The Forward-Looking Information ("FLI") in this presentation relates to future events or our future performance. The FLI are based on a number of assumptions and are associated with a number of risks, uncertainties and other unknown factors that may cause our actual results, levels of a ...

2024 Annual Results February 26, 2025 NYSE/TSX:SII Forward-looking Statements Sprott Inc. | 2 Speakers Whitney George, CEO, Sprott Inc. Kevin Hibbert, CFO, Sprott Inc. John Ciampaglia, CEO, Sprott Asset Management Sprott Inc. | 3 2024 Review Certain statements in this presentation or the accompanying oral remarks contain forward-looking information and forward-looking statements (collectively referred to herein as the "Forward-Looking Statements") within the meaning of applicable Canadian and U.S. securitie ...